Article Information
History
- June 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sunhwa Kim1,*,
- Ashmita Saigal1,
- Weilong Zhao2,
- Peyvand Amini1,
- Alex M. Tamburino3,
- Subharekha Raghavan4 and
- Maarten Hoek1,#a
- 1Cardiovascular, Metabolic, Renal, Ophthalmology Biology-Discovery, Merck & Co., Inc., South San Francisco, CA, USA
- 2Scientific informatics, Merck & Co., Inc., South San Francisco, CA, USA
- 3Discovery pGx, Merck & Co., Inc., West Point, PA, USA
- 4Chemistry Capabilities Accelerate Therapeutics, Merck & Co., Inc., Kenilworth, NJ, USA
- ↵*Corresponding author: Sunhwa Kim (sunhwa.kim{at}merck.com)
Posted June 14, 2020.
Identification of the Molecular Basis of Anti-fibrotic Effects of Soluble Guanylate Cyclase Activator Using the Human Lung Fibroblast Phosphoproteome
